Sun Pharmaceutical Industries Share Price Today - Live Blog for July 22, 2025

Following a noteworthy 0.02% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,679.00. When it comes to valuation, this stock has a PE ratio of 37.1400, with the industry PE ratio at 35.9113.

With a remarkable 0.10% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,677.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 37.1400, while the industry's PE ratio is 35.9113.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.11% drop, and it's now trading at ₹1,676.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.00% increase and currently trading at ₹1,677.50 per share. This upward trajectory is turning heads in the market.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.00% recently. As of now, this stock is actively trading at a current market price of ₹1,677.50 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd witnessed a -0.07% decrease in its share price, and it is currently trading at ₹1,679.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.1400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,679.15. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Demonstrating a commendable 0.07% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,679.60. In terms of valuation, the stock maintains a PE ratio of 37.1400, while the industry PE ratio stands at 35.9113.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.26%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,677.35, and market participants are assessing the implications. The stock has a PE ratio of 37.1400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.26%, a situation worth noting. At present, the stock is trading at ₹1,677.35. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.1400, while the industry PE ratio is 35.9113.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.12% gain, with the share price now at ₹1,682.80. Notably, the stock's PE ratio stands at 37.1400, and its Return on Equity (ROE) is 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.07% drop, and it's now trading at ₹1,680.75 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.07% increase and currently trading at ₹1,680.20 per share. This upward trajectory is turning heads in the market.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,680.20 per share.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.07% upswing, and it's currently trading at ₹1,678.00 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd witnessed a -0.07% drop in its share price and is currently trading at ₹1,677.95. With the stock's PE at 37.1400 and the industry PE at 35.9113, investors are weighing their options.

Following a noteworthy 0.16% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,679.05. When it comes to valuation, this stock has a PE ratio of 37.1400, with the industry PE ratio at 35.9113.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.08% increase and currently trading at ₹1,676.40 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.22% drop, and it's now trading at ₹1,675.05 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.04% slump and is currently trading at ₹1,678.75. While the stock maintains a PE ratio of 37.1400, the industry PE is 35.9113, raising questions about valuation.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.39% gain, with the share price now at ₹1,680.45. Notably, the stock's PE ratio stands at 37.1400, and its Return on Equity (ROE) is 15.1334%.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.00%, reaching a current market price of ₹1,675.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,675.55. Investors should examine the factors driving this decline. The stock's PE ratio is 37.1400, whereas the industry PE ratio stands at 35.9113.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.14%, and it is currently trading at ₹1,676.35. Additionally, the stock maintains a PE ratio of 37.1400, while the industry PE is 35.9113.

Sun Pharmaceutical Industries Ltd witnessed a -0.54% drop in its share price and is currently trading at ₹1,674.90. With the stock's PE at 37.1400 and the industry PE at 35.9113, investors are weighing their options.

Sun Pharmaceutical Industries Ltd witnessed a -1.00% decrease in its share price, and it is currently trading at ₹1,683.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.1400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.